Sunday, October 24, 2021 4:30:28 PM
As per US Supreme Court guidelines & the accurate interpretation of USFDA laws & SEC Rules & Regulations about clinical trials, what matters is the “intent” of the responsible party (in this case it’s GTHP & it’s board). Their “intent” is to start US clinical trials “asap”. At least that’s what they have been claiming in their PRs. Their “intent” is NOT to “keep on preparing indefinitely” for starting US clinical trials. So on their clinicaltrials.gov entry they “must” have mentioned “Contacts & Locations” of all those sites that they are targeting for starting US clinical trials. Since they haven’t mentioned all this information this entry has absolutely no meaning from the perspectives of those who are truly “educated & informed” & those who know laws, rules & regulations versus those who “claim” to be so-called educated.
Not mentioning “Contacts & Locations” information “inadvertently” is not a civil or criminal violation. However when stockholders repeatedly warned/informed you about this potential “violation” & then “deliberately” ignoring those warnings so as to “hide” relevant information from stockholders is a civil as well as criminal offence.
Next week hopefully FDA SEC & Department of Medical Devices of FDA will review all this & hopefully take some enforcement action if they deem necessary.
Recent GTHP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 06:36:25 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/20/2024 06:42:41 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 06:48:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 04:24:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 08:28:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2023 09:49:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2023 04:44:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/07/2023 07:53:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 07:00:31 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM